These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. Jain A; Lamark T; Sjøttem E; Larsen KB; Awuh JA; Øvervatn A; McMahon M; Hayes JD; Johansen T J Biol Chem; 2010 Jul; 285(29):22576-91. PubMed ID: 20452972 [TBL] [Abstract][Full Text] [Related]
6. The autophagy pathway maintained signaling crosstalk with the Keap1-Nrf2 system through p62 in auditory cells under oxidative stress. Hayashi K; Dan K; Goto F; Tshuchihashi N; Nomura Y; Fujioka M; Kanzaki S; Ogawa K Cell Signal; 2015 Feb; 27(2):382-93. PubMed ID: 25435427 [TBL] [Abstract][Full Text] [Related]
7. NBR1-mediated p62-liquid droplets enhance the Keap1-Nrf2 system. Sánchez-Martín P; Sou YS; Kageyama S; Koike M; Waguri S; Komatsu M EMBO Rep; 2020 Mar; 21(3):e48902. PubMed ID: 31916398 [TBL] [Abstract][Full Text] [Related]
8. Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination. Hast BE; Cloer EW; Goldfarb D; Li H; Siesser PF; Yan F; Walter V; Zheng N; Hayes DN; Major MB Cancer Res; 2014 Feb; 74(3):808-17. PubMed ID: 24322982 [TBL] [Abstract][Full Text] [Related]
9. Caffeic acid inhibits HCV replication via induction of IFNα antiviral response through p62-mediated Keap1/Nrf2 signaling pathway. Shen J; Wang G; Zuo J Antiviral Res; 2018 Jun; 154():166-173. PubMed ID: 29656059 [TBL] [Abstract][Full Text] [Related]
10. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Lau A; Wang XJ; Zhao F; Villeneuve NF; Wu T; Jiang T; Sun Z; White E; Zhang DD Mol Cell Biol; 2010 Jul; 30(13):3275-85. PubMed ID: 20421418 [TBL] [Abstract][Full Text] [Related]
11. An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-κB signalling and is associated with reduced phosphorylation of p62. Foster A; Scott D; Layfield R; Rea SL Mol Cell Neurosci; 2019 Jul; 98():32-45. PubMed ID: 30954537 [TBL] [Abstract][Full Text] [Related]
12. Toll-Like Receptor Signaling Induces Nrf2 Pathway Activation through p62-Triggered Keap1 Degradation. Yin S; Cao W Mol Cell Biol; 2015 Aug; 35(15):2673-83. PubMed ID: 26012548 [TBL] [Abstract][Full Text] [Related]
13. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway. Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046 [TBL] [Abstract][Full Text] [Related]
14. HCV-induced oxidative stress by inhibition of Nrf2 triggers autophagy and favors release of viral particles. Medvedev R; Ploen D; Spengler C; Elgner F; Ren H; Bunten S; Hildt E Free Radic Biol Med; 2017 Sep; 110():300-315. PubMed ID: 28673615 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers. Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257 [TBL] [Abstract][Full Text] [Related]
16. ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling. Goode A; Rea S; Sultana M; Shaw B; Searle MS; Layfield R Mol Cell Neurosci; 2016 Oct; 76():52-58. PubMed ID: 27554286 [TBL] [Abstract][Full Text] [Related]
17. Structural and Dynamic Characterization of Mutated Keap1 for Varied Affinity toward Nrf2: A Molecular Dynamics Simulation Study. Cheng IC; Chen YJ; Ku CW; Huang YW; Yang CN J Chem Inf Model; 2015 Oct; 55(10):2178-86. PubMed ID: 26348991 [TBL] [Abstract][Full Text] [Related]
18. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis. Stępkowski TM; Kruszewski MK Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136 [TBL] [Abstract][Full Text] [Related]
20. Interdisciplinary Study of the Effects of Dipeptidyl-Peptidase III Cancer Mutations on the KEAP1-NRF2 Signaling Pathway. Matić S; Tomašić Paić A; Sobočanec S; Pinterić M; Pipalović G; Martinčić M; Matovina M; Tomić S Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]